Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Welcome scoob. I will not give you a direct answer but I will tell you why I chose to go long. I'll give you some info followed by links so you can do your DD and determine for yourself.
Bioheart is a growing company in a growing sector. They have been around for years and are currently in phase 3 trials for FDA approval of its lead product Myocell in the US. Recently BioHeart released phase 1 data for their adipocell Angel trial. BioHeart began forming strategic partnerships worldwide offering thief products and services and have now began seeing increased revenues quarter over quarter. They also recently secured a 3 million plus investment by Manga.
http://www.bioheartinc.com/AboutUs/Overview
http://www.bioheartinc.com/assets/press/2BIOHEART,INC.REPORTSSIGNIFICANTREVENUEINCREASES.pdf
http://www.bioheartinc.com/assets/press/BIOHEARTRELEASESQ2FINANCIALINFORMATIONSHOWINGGROWTH.pdf
http://www.bioheartinc.com/assets/press/2BIOHEARTANNOUNCESGRANDOPENINGOFMAGNUMCELLTHERAPIES.pdf
http://www.bioheartinc.com/assets/press/BIOHEARTANNOUNCESCLINICALTRIALSININDIA.pdf
http://www.bioheartinc.com/assets/press/MagnaPressRelease.pdf
http://www.bioheartinc.com/assets/press/BioheartAnnouncesPartnershipinColombia.pdf
Those are just a few highlights. The last 10Q shows revenues above 1.5 mil this year compared to 56K last year.
Check out this link for all the PRs
http://www.bioheartinc.com/News-Events/NewsReleases
Nice find GS. I assume a PR is coming tomorrow. IMO
New website launched includes BioHeart.
http://globalstemcellfound.com/advisory-board/
Yes. And it's strange to me how the majority of the time there is 10,000 on the bid and 10,000 on the ask day in and day out.
Do most traders buy and sell in blocks of 10,000 shares at a time?
I'm getting tired of the manipulation that clearly goes on.
Who, what, where, when, why?
(Copy paste)
Yup, amateurs...
GREEN ON MONDAY IMO.
No worries. But IMO I wouldn't be surprised if the remaining 3mil were sold in no more than 6 large blocks of 500k
"Ways of a market maker" grabbed this from a different board
http://shockertrades.blogspot.com/2011/05/market-maker-speaks-out-ways-of-market.html
http://www.digitaljournal.com/pr/2293676
Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
"The key players of the global stem cells market include California Stem Cell Inc., Cellular Engineering Technologies, Biotime Inc., Brainstorm Cell Therapeutics, Cytori Therapeutics Inc., Celgene Corporation Inc., Bioheart, Cellartis AB, Osiris Therapeutics, Angel Biotechnology, Advanced Cell Technology, and Stemcelltechnologies Inc."
Saw this early this morning. Mike has an excellent reputation and track record. IMO he is doing an exceptional job here at BioHeart.
Seminar on Regenerative Medicine Open to Public
"Schmidt, who is certified to administer stem cell therapy, was trained by Bioheart Chief Scientific Officer Kristin Comella. Comella has been recognized as a national leader in stem cell therapy."
http://www.prweb.com/releases/2014/10/prweb12289534.htm
The shorts are in a panic...
Excellent day today. 10Q due around November 14 (based on last years filing) expect a significant increase in Revenues.
BioHeart will soon be IMO trading in the dollars. GLTA.
Increased partnerships and revenues quarter over quarter. Next 10Q will tell the same story of increased revenues including revenues beyond 1 million for the year thus far. IMO
Myocell phase 3 update coming soon IMO now that we got the financing to continue the trials
Absolutely.
Perfect post. BioHearts value will soon be represented in the pps as the business plan continues to perfectly align. Partnerships, successful trials, increased revenues, financing etc!!! This is what investing is all about!! Buy low, see the big picture bet on a green future!!
UP 105% YEAR TO DATE!!! EVEN BIGGER WOW IMO!!!
Good day today. Expect MyoCell update soon IMO. I've seen bits and clues about it on BioHearts Twitter
https://mobile.twitter.com/BioheartInc
Agree.
Excellent post.
Excellent read.
Excited for trading to start next week. BioHeart IMO will get ever closer to its PPS being a representation of its true value.
Disagree.
Definitely IMO. I can see it running and maintaining until the next 10Q on or around November 14th IMO that will show significant increase in revenues quarter over quarter. Third times the charms IMO. Sky's the limit and I'm more excited than ever for BHRT. GLTA!!
Yup, it's going to happen "upon consummation of financing".
Haha the shorts are in a panic!
Bioheart, Inc. Completes Financing With Magna
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, a Florida corporation, is pleased to announce the closing of a common stock purchase agreement for a $3 million Equity Enhancement Program ("EEP") with a Magna affiliate fund, Magna Equities II, LLC (the "Investor"). The EEP allows, but does not obligate the Company to issue and sell up to $3,000,000 worth of the Company's common stock to the Investor from time to time, over the 24-month term of the purchase agreement.
In connection with the execution of the purchase agreement, the Company and the Investor also entered into a registration rights agreement, whereby, the Company has agreed to file an initial registration statement with the U.S. Securities & Exchange Commission ("SEC"). In addition, Bioheart is pleased to announce that the Company has completed a $307,500 financing through a convertible note issued to Magna, as previously reported on the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 10, 2014. Details of both transactions are outlined in the public filings.
Company CEO, Mr. Mike Tomas, stated, "We are very pleased to enter into these agreements with Magna. These financings help Bioheart proceed with our trials efforts and continue our pursuit to take our therapies to the bedside."
Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2013.
Nice find JW. The industry knows the potential of BioHearts lead products. IMO
You were right on point GS. 30 min before close I almost sold a position I have elsewhere to grab a larger stake at the current pps.... I got caught up washing dishes though haha
Definitely a step forward! I don't think it's a coincidence that we get this news a couple weeks before the 10Q due next month!
I was about to post and ask you what your thoughts were on this?
Thanks Hop. Your support here at BioHeart is greatly appreciated.
Yes. 99.99% likely.
I'm invested as a shareholder. If I didn't believe in the company I'd take the value of shares elsewhere. I'm invested because I believe in the fruition of the company's pipeline. I would not invest in a company I did not trust, and voting no would mean I did not trust Ocata with my shares.... In which case, if it were the case, I would take my investment elsewhere. IMO standing back and looking at the big picture... We are only a couple of months or less away from being up listed and beginning phase 2 trials. This company IMO would not dare "slip" again (reference to legacy issues) because that would mean IMO the end for Ocata as shareholders will not stand to be duped twice. Everything the management team has said would happen has occurred.... And more with the addition of unexpected patent grants etc.
I'm excited to close the year with new milestones being met. I do not worry about the price manipulation occurring by the wolves that are feeding off the PPS weekly as they will be put to rest IMO by the end of the year as we move into the new territory that is the Nasdaq.